Michael Sheehan
Psychiatry · Tampa, FLNPI 1528060597
Payments from drug & device makers
Across 423 payments — averaging $30.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Otsuka America Pharmaceutical, Inc.$1K
- Neurocrine Biosciences, Inc.$1K
- Johnson & Johnson$1K
- AbbVie$942
- Alkermes, Inc.$734
- Sunovion Pharmaceuticals Inc.$725
- plus $7K from 37 others
What the payments were for
- Food & beverage$12,57199%
- Education$1381%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- LYBALVI$909
- VRAYLAR$347
- LATUDA$249
- Dayvigo$246
- Auvelity$237
- SUBLOCADE$234
- INGREZZA$232
- INVEGA SUSTENNA$224
- WEB$144
- LVIS$144
- HydroFrame Coil$144
- HydroSoft 3D Coil$144
- CAPLYTA$143
- SPRAVATO$127
- PERSERIS$123
- SUNOSI$123
- REXULTI$122
- VNS - Symmetry$121
- INVEGA TRINZA$121
- Austedo XR$116
How this compares
$12,709 in reported general payments places this provider in the 85th percentile of 2,059 psychiatry providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| VraylarCariprazine Hcl | 18 | $24,521 |
| Lisdexamfetamine Dimesylate | 24 | $7,124 |
| Fluvoxamine Maleate ErFluvoxamine Maleate | 13 | $5,824 |
| Aripiprazole | 84 | $4,482 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 112 | $4,227 |
| Alprazolam | 355 | $2,490 |
| KlonopinClonazepam | 13 | $2,343 |
| Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine | 43 | $2,301 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 44 | $2,069 |
| Bupropion XlBupropion Hcl | 90 | $1,918 |
| Clonazepam | 156 | $1,680 |
| Buprenorphine Hcl | 31 | $1,596 |
| Quetiapine Fumarate | 92 | $1,471 |
| Duloxetine Hcl | 85 | $1,437 |
| Methylphenidate Hcl | 26 | $938 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieVraylar | $942 | $24,52118 claims |
| Almatica Pharma LLCSertraline Hcl | $319 | $37754 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 2,059 psychiatry providers in Florida.
Other psychiatry in Tampa
- Kelley WilsonTampa$11.1M
- Jamie FernandezTampa$2.9M
- Jean FilsTampa$1.1M
- Daniel FallonTampa$724K
- Edwin GomezWeston$24.9M
- Rishi KakarTamarac$23.9M
- Peter VentreOakland Park$18.7M
- Jose GamezHialeah$14.8M
- John JoyceJacksonville$13.6M
- Silvia Silva-DulucMiami$11.7M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.